CN1486736A - A Chinese medicinal composition for treating hepatic fibrosis and liver cirrhosis, KANGJINRUANGGAN pill - Google Patents
A Chinese medicinal composition for treating hepatic fibrosis and liver cirrhosis, KANGJINRUANGGAN pill Download PDFInfo
- Publication number
- CN1486736A CN1486736A CNA031528074A CN03152807A CN1486736A CN 1486736 A CN1486736 A CN 1486736A CN A031528074 A CNA031528074 A CN A031528074A CN 03152807 A CN03152807 A CN 03152807A CN 1486736 A CN1486736 A CN 1486736A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- liver
- pill
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006187 pill Substances 0.000 title claims abstract description 23
- 206010019668 Hepatic fibrosis Diseases 0.000 title claims abstract description 14
- 208000019425 cirrhosis of liver Diseases 0.000 title claims abstract description 12
- 239000000203 mixture Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 34
- 210000004185 liver Anatomy 0.000 claims abstract description 30
- 210000003038 endothelium Anatomy 0.000 claims abstract description 20
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 10
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 6
- 241000405414 Rehmannia Species 0.000 claims abstract description 6
- 108010052008 colla corii asini Proteins 0.000 claims description 19
- 210000000582 semen Anatomy 0.000 claims description 19
- 241000222640 Polyporus Species 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000001035 drying Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 241001489978 Eupolyphaga Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000011010 flushing procedure Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 244000164439 Curcuma angustifolia Species 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 208000019423 liver disease Diseases 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 102000008186 Collagen Human genes 0.000 abstract description 3
- 108010035532 Collagen Proteins 0.000 abstract description 3
- 206010016654 Fibrosis Diseases 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000008021 deposition Effects 0.000 abstract description 3
- 230000006866 deterioration Effects 0.000 abstract description 3
- 230000004761 fibrosis Effects 0.000 abstract description 3
- 208000004930 Fatty Liver Diseases 0.000 abstract description 2
- 206010019646 Hepatic cyst Diseases 0.000 abstract description 2
- 206010019695 Hepatic neoplasm Diseases 0.000 abstract description 2
- 206010019708 Hepatic steatosis Diseases 0.000 abstract description 2
- 206010041660 Splenomegaly Diseases 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 208000010706 fatty liver disease Diseases 0.000 abstract description 2
- 208000014018 liver neoplasm Diseases 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract description 2
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 241000931143 Gleditsia sinensis Species 0.000 abstract 1
- 241000222684 Grifola Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 241000301400 Trogopterus Species 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 230000000593 degrading effect Effects 0.000 abstract 1
- 210000003608 fece Anatomy 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 230000006870 function Effects 0.000 description 9
- 231100000614 poison Toxicity 0.000 description 7
- 208000002672 hepatitis B Diseases 0.000 description 6
- 239000002574 poison Substances 0.000 description 5
- 241000407170 Curcuma Species 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 241000700721 Hepatitis B virus Species 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000003240 portal vein Anatomy 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A compound Chinese medicinal preparation for treating hepatic fibrosis and liver cirrhosis, KANGJINRUANGGAN pill, is characterized in that the raw material medicaments comprise: 5-15 parts of peach kernel, 5-15 parts of prepared pangolin scales, 7-20 parts of prepared turtle shell, 5-15 parts of panax notoginseng, 5-15 parts of ground beetle, 10-20 parts of salvia miltiorrhiza, 5-15 parts of red paeony root, 5-15 parts of Chinese honeylocust needle, 5-15 parts of trogopterus dung, 5-15 parts of angelica, 10-20 parts of prepared rehmannia root, 5-15 parts of donkey-hide gelatin, 10-20 parts of raw astragalus root, 5-15 parts of medlar, 5-15 parts of radix curcumae, 5-15 parts of endothelium corneum gigeriae galli, 10-20 parts of grifola, 5-15 parts of prepared nutgrass galingale rhizome, 5-15 parts of curcuma zedoary, 10. The invention is mainly used for treating chronic liver disease, hepatic fibrosis, liver cirrhosis, splenomegaly, fatty liver, hepatic cyst and liver tumor. It has effects in promoting blood circulation, dispelling blood stasis, softening and softening liver, resisting hepatic fibrosis, inhibiting fat deposition in liver, relieving chronic liver disease deterioration and fibrosis, degrading abnormal collagen in liver, reducing portal pressure, and reducing spleen.
Description
Technical field
The present invention relates to one is the preparation that raw material is made with the animals and plants Chinese crude drug, and specifically a kind of Chinese traditional compound medicine-anti-fine soft liver for the treatment of hepatic fibrosis, liver cirrhosis is fried in shallow oil pill.
Background technology
Hepatitis B is a kind of common chronic infectious disease, its sickness rate and fatality rate are higher, utilize the method for Chinese medicine Drug therapy hepatitis B a lot of at present, the Chinese patent medicine of a lot of treatment hepatitis B is also arranged on the market, but the problem that these medicine ubiquities courses of treatment is long, uncertain therapeutic efficacy is cut.
The object of the present invention is to provide a kind of blood circulation promoting and blood stasis dispelling that has, the soft liver of easing the affected liver, anti-hepatic fibrosis, suppress the intrahepatic fat deposition, alleviate the deterioration and the fibrosis of chronic hepatopathy, unusual collagen protein reduces portal vein pressure in the degraded liver, dwindles a kind of Chinese traditional compound medicine-anti-fine soft liver for the treatment of hepatic fibrosis, liver cirrhosis of spleen and fries in shallow oil pill.
Solution of the present invention is to be diagnosed as foundation with doctor trained in Western medicine, takes as the leading factor with tcm theory, and comprehensive Tibetan medicine, Dai Nationality's medicine, state of Chinese medicine in Japan and Korea S's treating the liver method are through the clinical verification in year surplus 20.Have a liking for the heresy invasion of the hepatitis B virus of liver and epidemic disease poison, healthy energy is risen vigorously anti-evilly in the human body, causes struggle between vital QI and pathogen, is just winning then heresy but, liver by force then poison move back, hepatitis B virus is eliminated out external, does not then fall ill; Pestilence in poison is evil, vital QI cannot conquer pathogen, liver function weakens, and causes the hepatitis B outbreak then.When liver function weakens or epidemic disease poison when flourishing, then cause the disorder of liver negative and positive of qi and blood, pathological product is piled up, and the state of an illness is increased the weight of gradually and forms a series of vicious cycle, develops into liver cirrhosis, hepatocarcinoma.Hepatopathy and spleen and kidney have weakened function.
Material medicine weight proportion of the present invention is:
Semen Persicae 5-15 stir-baked SQUAMA MANITIS 5-15 Carapax Trionycis (processed) 7-20 Radix Notoginseng 5-15 Eupolyphaga Seu Steleophaga 5-15
Radix Salviae Miltiorrhizae 10-20 Radix Paeoniae Rubra 5-15 SPINA GLEDITSIAE 5-15 Oletum Trogopterori 5-15 Radix Angelicae Sinensis 5-15
Radix Rehmanniae Preparata 10-20 Colla Corii Asini 5-15 Radix Astragali 10-20 Fructus Lycii 5-15 Radix Curcumae 5-15
Endothelium Corneum Gigeriae Galli 5-15 Polyporus 10-20 Rhizoma Cyperi (processed) 5-15 Rhizoma Curcumae 5-15 Pericarpium Arecae 10-30
Ramulus Euonymi 15-45 Herba Hedyotidis Diffusae 15-45
Material medicine preferred weight ratio range of the present invention is:
Semen Persicae 10-15 stir-baked SQUAMA MANITIS 10-15 Carapax Trionycis (processed) 15-20 Radix Notoginseng 10-15 Eupolyphaga Seu Steleophaga 10-15
Radix Salviae Miltiorrhizae 15-20 Radix Paeoniae Rubra 10-15 SPINA GLEDITSIAE 10-15 Oletum Trogopterori 10-15 Radix Angelicae Sinensis 10-15
Radix Rehmanniae Preparata 15-20 Colla Corii Asini 10-15 Radix Astragali 15-20 Fructus Lycii 10-15 Radix Curcumae 10-15
Endothelium Corneum Gigeriae Galli 10-15 Polyporus 15-20 Rhizoma Cyperi (processed) 10-15 Rhizoma Curcumae 10-15 Pericarpium Arecae 20-30
Ramulus Euonymi 30-45 Herba Hedyotidis Diffusae 30-45
Material medicine optimum weight proportioning of the present invention is:
Semen Persicae 10 stir-baked SQUAMA MANITISs 10 Carapax Trionycis (processed)s 15 Radix Notoginsengs 10 Eupolyphaga Seu Steleophagas 10 Radix Salviae Miltiorrhizaes 10
Radix Paeoniae Rubra 10 SPINA GLEDITSIAEs 10 Oletum Trogopteroris 10 Radix Angelicae Sinensis 10 Radix Rehmanniaes Preparata 15 Colla Corii Asini 10
Radix Astragali 15 Fructus Lyciis 10 Radix Curcumaes 10 Endothelium Corneum Gigeriae Galli 10 Polyporus 15 Rhizoma Cyperi (processed) 10
Rhizoma Curcumae 10 Pericarpium Arecae 20 Ramulus Euonymis 30 Herba Hedyotidis Diffusaes 30
Above-mentioned described each component is made anti-fine soft liver fries in shallow oil the pill method for producing medicines and is:
1, with said medicine (except that Semen Persicae, Oletum Trogopterori, Radix Rehmanniae Preparata, Colla Corii Asini, Endothelium Corneum Gigeriae Galli, Polyporus) with drying after the flushing with clean water;
2, get Pericarpium Arecae, Ramulus Euonymi, Herba Hedyotidis Diffusae and add 3 liters of calculating of water by every kilogram, decocted 30 minutes, taking liquid is retained.
3, get Chinese crude drug after the cleaning and Semen Persicae, Radix Rehmanniae Preparata, Colla Corii Asini, the Endothelium Corneum Gigeriae Galli hybrid process becomes 120 order fineness powder;
4, get Chinese medicinal powder use among decocted liquid medicine be mixed and made into the water pill agent, behind the drying and sterilizing strong protecting liver fry in shallow oil pill.
The present invention cures mainly chronic hepatopathy, hepatic fibrosis, liver cirrhosis, splenomegaly, fatty liver, hepatic cyst, liver neoplasm.It has blood circulation promoting and blood stasis dispelling, the soft liver of easing the affected liver, and anti-hepatic fibrosis suppresses the intrahepatic fat deposition, alleviates the deterioration and the fibrosis of chronic hepatopathy, and unusual collagen protein reduces portal vein pressure, a kind of function for the treatment of hepatic fibrosis, liver cirrhosis of dwindling spleen in the degraded liver.
Instructions of taking of the present invention: every day 3 times, each 6 grams, three months is a course of treatment.
Strong protecting liver of the present invention is fried in shallow oil the clinical use result of pill and is shown that following advantage is arranged:
1, to select the natural animal-plant medical material for use be raw material in the present invention, and each component meets tcm theory, meets the pharmaceutical control law regulation, nontoxic to human body.
2, the present invention has detoxifcation removing toxic substances function, can remove hepatitis B virus in the body, suppresses it and duplicates, and gets rid of toxin, makes hepatocyte recover normal.
3, liver and kidney tonifying of the present invention is strengthened and the liver protecting function, strengthens cellular immune function, changes the hyperfunction state of humoral immunization, reaches YIN and YANG in a relative equilibrium, regulates immunity.
4, the present invention has the cancer-resisting function, prevents the variation that liver is thin, reduces or removing hepatitis B--the incidence rate of hepatocarcinoma, by clinical observation in more than 20 years, for a long time with not finding the canceration patient behind the medicine of the present invention.
5, the present invention has transaminase lowering, and stabilised bloodization is given birth to function, and the generation that can effectively control inflammation promotes hepatocellular reparative regeneration.
6, the present invention has transaminase lowering, and stabilised bloodization is given birth to function, and the generation that can effectively control inflammation promotes hepatocellular reparative regeneration.
7, the present invention has the promoting the function of the gallbladder to alleviate jaundice effect.Gallbladder is attached to liver, pestilence in poison is evil, and the excessive then jaundice of bile takes place.The present invention reaches the purpose that diminishes inflammation by the removing toxic substances function of gallbladder promoting.
8, the present invention can remove the clinical symptoms of hepatitis B patient, and is quick and effective.Drug effect by adjusting liver function, reaches equilibrium between yin and yang in the body in liver spleen kidney and other internal organs meridians, and clinical symptoms can be improved in the back of taking medicine in the short-term scope.
The specific embodiment
Embodiment 1:
Take by weighing raw material (kilogram) by following proportioning:
Semen Persicae 10 stir-baked SQUAMA MANITISs 10 Carapax Trionycis (processed)s 15 Radix Notoginsengs 10 Eupolyphaga Seu Steleophagas 10 Radix Salviae Miltiorrhizaes 15
Radix Paeoniae Rubra 10 SPINA GLEDITSIAEs 10 Oletum Trogopteroris 10 Radix Angelicae Sinensis 10 Radix Rehmanniaes Preparata 15 Colla Corii Asini 10
Radix Astragali 15 Fructus Lyciis 10 Radix Curcumaes 10 Endothelium Corneum Gigeriae Galli 10 Polyporus 15 Rhizoma Cyperi (processed) 10 Rhizoma Curcumae 10 Pericarpium Arecae 20 Ramulus Euonymis 30 Herba Hedyotidis Diffusaes 30
With said medicine (removing Semen Persicae, Oletum Trogopterori, Radix Rehmanniae Preparata, Colla Corii Asini, Endothelium Corneum Gigeriae Galli, Polyporus) with drying after the flushing with clean water; Get Pericarpium Arecae, Ramulus Euonymi, Herba Hedyotidis Diffusae and add 240 liters in water, decocted 30 minutes, taking liquid is retained; Get Chinese crude drug behind the cleaning, drying and Semen Persicae, Colla Corii Asini, Endothelium Corneum Gigeriae Galli, the Polyporus hybrid process becomes 120 order fineness powder; Get Chinese medicinal powder and be mixed and made into the water pill agent with decocted liquid medicine among above-mentioned, pill diameter 5mm, behind the drying and sterilizing anti-fine soft liver fry in shallow oil pill.
Embodiment 2:
Take by weighing raw material (kilogram) by following proportioning:
Semen Persicae 5 stir-baked SQUAMA MANITISs 5 Carapax Trionycis (processed)s 10 Radix Notoginsengs 5 Eupolyphaga Seu Steleophagas 5 Radix Salviae Miltiorrhizaes 10
Radix Paeoniae Rubra 5 SPINA GLEDITSIAEs 5 Oletum Trogopteroris 5 Radix Angelicae Sinensis 5 Radix Rehmanniaes Preparata 10 Colla Corii Asini 5
Radix Astragali 10 Fructus Lyciis 5 Radix Curcumaes 5 Endothelium Corneum Gigeriae Galli 5 Polyporus 10 Rhizoma Cyperi (processed) 5
Rhizoma Curcumae 5 Pericarpium Arecae 10 Ramulus Euonymis 15 Herba Hedyotidis Diffusaes 15
With said medicine (removing Semen Persicae, Oletum Trogopterori, Radix Rehmanniae Preparata, Colla Corii Asini, Endothelium Corneum Gigeriae Galli, Polyporus) with drying after the flushing with clean water; Get Pericarpium Arecae, Ramulus Euonymi, Herba Hedyotidis Diffusae and add 120 liters in water, decocted 30 minutes, taking liquid is retained; Get Chinese crude drug behind the cleaning, drying and Semen Persicae, Colla Corii Asini, Endothelium Corneum Gigeriae Galli, the Polyporus hybrid process becomes 120 order fineness powder; Get Chinese medicinal powder and be mixed and made into the water pill agent with decocted liquid medicine among above-mentioned, pill diameter 5mm, behind the drying and sterilizing anti-fine soft liver fry in shallow oil pill.
Embodiment 3:
Take by weighing raw material (kilogram) by following proportioning:
Semen Persicae 15 stir-baked SQUAMA MANITISs 15 Carapax Trionycis (processed)s 20 Radix Notoginsengs 15 Eupolyphaga Seu Steleophagas 15 Radix Salviae Miltiorrhizaes 20
Radix Paeoniae Rubra 15 SPINA GLEDITSIAEs 15 Oletum Trogopteroris 15 Radix Angelicae Sinensis 15 Radix Rehmanniaes Preparata 20 Colla Corii Asini 15
Radix Astragali 20 Fructus Lyciis 15 Radix Curcumaes 15 Endothelium Corneum Gigeriae Galli 15 Polyporus 20 Rhizoma Cyperi (processed) 15 Rhizoma Curcumae 15 Pericarpium Arecae 30 Ramulus Euonymis 45 Herba Hedyotidis Diffusaes 45
With said medicine (removing Semen Persicae, Oletum Trogopterori, Radix Rehmanniae Preparata, Colla Corii Asini, Endothelium Corneum Gigeriae Galli, Polyporus) with drying after the flushing with clean water; Get Pericarpium Arecae, Ramulus Euonymi, Herba Hedyotidis Diffusae and add 360 liters in water, decocted 30 minutes, taking liquid is retained; Get Chinese crude drug behind the cleaning, drying and Semen Persicae, Colla Corii Asini, Endothelium Corneum Gigeriae Galli, the Polyporus hybrid process becomes 120 order fineness powder; Get Chinese medicinal powder and be mixed and made into the water pill agent with decocted liquid medicine among above-mentioned, pill diameter 5mm, behind the drying and sterilizing anti-fine soft liver fry in shallow oil pill.
Claims (3)
1, a kind of Chinese traditional compound medicine-anti-fine soft liver for the treatment of hepatic fibrosis, liver cirrhosis is fried in shallow oil pill, it is characterized in that its material medicine weight proportion is:
Semen Persicae 5-15 stir-baked SQUAMA MANITIS 5-15 Carapax Trionycis (processed) 7-20 Radix Notoginseng 5-15 Eupolyphaga Seu Steleophaga 5-15
Radix Salviae Miltiorrhizae 10-20 Radix Paeoniae Rubra 5-15 SPINA GLEDITSIAE 5-15 Oletum Trogopterori 5-15 Radix Angelicae Sinensis 5-15
Radix Rehmanniae Preparata 10-20 Colla Corii Asini 5-15 Radix Astragali 10-20 Fructus Lycii 5-15 Radix Curcumae 5-15
Endothelium Corneum Gigeriae Galli 5-15 Polyporus 10-20 Rhizoma Cyperi (processed) 5-15 Rhizoma Curcumae 5-15 Pericarpium Arecae 10-30
Ramulus Euonymi 15-45 Herba Hedyotidis Diffusae 15-45
At first, will be except that Semen Persicae, Oletum Trogopterori, Radix Rehmanniae Preparata, Colla Corii Asini, Endothelium Corneum Gigeriae Galli, Polyporus outer said medicine is dried after with flushing with clean water;
Secondly, get Pericarpium Arecae, Ramulus Euonymi, Herba Hedyotidis Diffusae and add 3 liters of calculating of water, decocted the taking liquid retention 30 minutes by every kilogram.
Then, get Chinese crude drug after the cleaning and Semen Persicae, Radix Rehmanniae Preparata, Colla Corii Asini, the Endothelium Corneum Gigeriae Galli hybrid process becomes 120 order fineness powder;
At last, get Chinese medicinal powder use among decocted liquid medicine be mixed and made into the water pill agent, behind the drying and sterilizing strong protecting liver fry in shallow oil pill.
2, fry in shallow oil pill, it is characterized in that its material medicine preferred weight ratio range is according to the described a kind of Chinese traditional compound medicine-anti-fine soft liver for the treatment of hepatic fibrosis, liver cirrhosis of claim 1:
Semen Persicae 10-15 stir-baked SQUAMA MANITIS 10-15 Carapax Trionycis (processed) 15-20 Radix Notoginseng 10-15 Eupolyphaga Seu Steleophaga 10-15
Radix Salviae Miltiorrhizae 15-20 Radix Paeoniae Rubra 10-15 SPINA GLEDITSIAE 10-15 Oletum Trogopterori 10-15 Radix Angelicae Sinensis 10-15
Radix Rehmanniae Preparata 15-20 Colla Corii Asini 10-15 Radix Astragali 15-20 Fructus Lycii 10-15 Radix Curcumae 10-15
Endothelium Corneum Gigeriae Galli 10-15 Polyporus 15-20 Rhizoma Cyperi (processed) 10-15 Rhizoma Curcumae 10-15 Pericarpium Arecae 20-30
Ramulus Euonymi 30-45 Herba Hedyotidis Diffusae 30-45.
3, fry in shallow oil pill, it is characterized in that its material medicine optimum weight proportioning is according to the described a kind of Chinese traditional compound medicine-anti-fine soft liver for the treatment of hepatic fibrosis, liver cirrhosis of claim 1:
Semen Persicae 10 stir-baked SQUAMA MANITISs 10 Carapax Trionycis (processed)s 15 Radix Notoginsengs 10 Eupolyphaga Seu Steleophagas 10 Radix Salviae Miltiorrhizaes 10
Radix Paeoniae Rubra 10 SPINA GLEDITSIAEs 10 Oletum Trogopteroris 10 Radix Angelicae Sinensis 10 Radix Rehmanniaes Preparata 15 Colla Corii Asini 10
Radix Astragali 15 Fructus Lyciis 10 Radix Curcumaes 10 Endothelium Corneum Gigeriae Galli 10 Polyporus 15 Rhizoma Cyperi (processed) 10
Rhizoma Curcumae 10 Pericarpium Arecae 20 Ramulus Euonymis 30 Herba Hedyotidis Diffusaes 30.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA031528074A CN1486736A (en) | 2003-08-19 | 2003-08-19 | A Chinese medicinal composition for treating hepatic fibrosis and liver cirrhosis, KANGJINRUANGGAN pill |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA031528074A CN1486736A (en) | 2003-08-19 | 2003-08-19 | A Chinese medicinal composition for treating hepatic fibrosis and liver cirrhosis, KANGJINRUANGGAN pill |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1486736A true CN1486736A (en) | 2004-04-07 |
Family
ID=34156578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA031528074A Pending CN1486736A (en) | 2003-08-19 | 2003-08-19 | A Chinese medicinal composition for treating hepatic fibrosis and liver cirrhosis, KANGJINRUANGGAN pill |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1486736A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006026926A1 (en) * | 2004-09-10 | 2006-03-16 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | A medicinal composition for treating hepatic fibrosis and its preparation |
| CN101549034B (en) * | 2009-05-07 | 2011-04-13 | 崔霞 | Medicine for treating liver cirrhosis |
| CN101461878B (en) * | 2009-01-09 | 2011-11-30 | 中山火炬职业技术学院 | Medicament composition for treating fatty liver and preparation method thereof |
| CN102824600A (en) * | 2012-08-20 | 2012-12-19 | 王三元 | Pure traditional Chinese medicine preparation for nourishing liver, protecting liver, softening liver and shrinking spleen and preparation method thereof |
| CN102895599A (en) * | 2012-10-30 | 2013-01-30 | 李华桥 | Traditional Chinese medical composition for treatment of cirrhosis |
| CN103301280A (en) * | 2013-06-27 | 2013-09-18 | 罗寿山 | Traditional Chinese medicine for treating cancer and liver cirrhosis |
| CN110064037A (en) * | 2019-05-20 | 2019-07-30 | 河南中医药大学 | A kind of Chinese medicine for treating hepatic cyst |
| CN111558020A (en) * | 2020-06-05 | 2020-08-21 | 王凤丽 | Medicine for treating liver cirrhosis |
-
2003
- 2003-08-19 CN CNA031528074A patent/CN1486736A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006026926A1 (en) * | 2004-09-10 | 2006-03-16 | Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | A medicinal composition for treating hepatic fibrosis and its preparation |
| CN101461878B (en) * | 2009-01-09 | 2011-11-30 | 中山火炬职业技术学院 | Medicament composition for treating fatty liver and preparation method thereof |
| CN101549034B (en) * | 2009-05-07 | 2011-04-13 | 崔霞 | Medicine for treating liver cirrhosis |
| CN102824600A (en) * | 2012-08-20 | 2012-12-19 | 王三元 | Pure traditional Chinese medicine preparation for nourishing liver, protecting liver, softening liver and shrinking spleen and preparation method thereof |
| CN102824600B (en) * | 2012-08-20 | 2014-07-23 | 王三元 | Pure traditional Chinese medicine preparation for nourishing liver, protecting liver, softening liver and shrinking spleen and preparation method thereof |
| CN102895599A (en) * | 2012-10-30 | 2013-01-30 | 李华桥 | Traditional Chinese medical composition for treatment of cirrhosis |
| CN103301280A (en) * | 2013-06-27 | 2013-09-18 | 罗寿山 | Traditional Chinese medicine for treating cancer and liver cirrhosis |
| CN110064037A (en) * | 2019-05-20 | 2019-07-30 | 河南中医药大学 | A kind of Chinese medicine for treating hepatic cyst |
| CN111558020A (en) * | 2020-06-05 | 2020-08-21 | 王凤丽 | Medicine for treating liver cirrhosis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN1683001A (en) | Chinese medicine for treating gout | |
| CN1785411A (en) | Chinese medicinal composition used for regulating menstruation and assisting pregnancy | |
| CN1486736A (en) | A Chinese medicinal composition for treating hepatic fibrosis and liver cirrhosis, KANGJINRUANGGAN pill | |
| CN1895619A (en) | Chinese-medicinal composition for preventing and treating liver disease and its preparation | |
| CN1895555A (en) | Bone-connecting pill and its preparation | |
| CN1539441A (en) | Compounded medicine for anti pathogeny and immunoenhancement | |
| CN1943764A (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN1063954C (en) | Chinese patent medicine-powder preparation for curing hepatitis B | |
| CN1169555C (en) | A Chinese medicinal decoction pill for treating hepatitis B | |
| CN100448468C (en) | Orally administered medicinal powder for treating gastric diseases | |
| CN1698808A (en) | Chinese medicinal composition for treating ulcer | |
| CN1112194C (en) | Compound yexiazhu medicine and preparing process thereof | |
| CN1319587C (en) | Medicine powder for liver and spleen diseases | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN1857630A (en) | Proteinuria treating Chinese medicine and its preparing method and use | |
| CN1319586C (en) | Medicinal composition for treating brain apoplexy | |
| CN1569095A (en) | Medicine for treating cerebral infarction | |
| CN1481876A (en) | Medication for virus hepatitis and hepatocirrhosis | |
| CN1042597C (en) | Vision-brighting and blood sugar decreasing composition and its produciton | |
| CN1086129C (en) | Hepatitis restoration pill | |
| CN1190229C (en) | Medicine for curing hepatitis B | |
| CN1544047A (en) | Chinese traditional medicine composition for treating cancer and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |